Watch out world, Yale Nephrology is taking on POCUS!!! Hands on faculty training session with Yale EM Ultrasound and Chris Moore today in the Yale Sim Lab!!! Abinet Aklilu was inspiring all of us with her skills.

EMPA-KIDNEY: Among a wide range of patients w/ CKD who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from CV causes (vs. placebo) ca. 2022 from NEJM #KidneyWk #Nephpearls 👉🏼 nejm.org/doi/full/10.10…

@jmdnephdoc doing what he does best at #KidneyWk. Great talk on Hepatorenal Syndrome and kidney injury markers. It’s good to know there is still some value in calculating FeNa. Yale Nephrology Ursula Brewster Sarthak Virmani